# DESCRIPTION

## BACKGROUND OF THE INVENTION

- introduce SphK2 and its role in cancer
- discuss limitations of current SphK2 inhibitors

## SUMMARY OF THE INVENTION

- introduce novel SphK2 inhibitors
- describe compounds of Formula I and II
- outline methods of treating cancer using Formula I and II compounds
- describe methods of inhibiting SphK2 using Formula I and II compounds
- provide specific examples of compounds and their uses

## DETAILED DESCRIPTION

- disclose compounds

### In Formula I:

- define chemical structure
- specify substituents
- describe compounds of Formula I and Formula III
- list compounds that inhibit SphK2
- describe compositions for treating diseases associated with SphK2 over-activation
- list pharmaceutical additives and excipients
- describe additional anti-cancer agents
- describe methods of administering compounds of Formulas I and II
- describe methods of treating cancer using compounds of Formulas I and II
- define effective amount
- describe treatment methods
- outline disease applications

## EXAMPLES

- provide synthesis examples

### Example 1

- prepare compound 26

### Example 2

- prepare compound 27

### Example 3

- prepare compounds 28-36

### Example 4

- prepare 4-alkoxyphenylpropanal compounds 14-19

### Example 5

- prepare 4-alkoxybenzaldehyde compounds 2-7

### Example 6

- prepare compounds 24, 46, 48, and 50 by Swern oxidation

### Example 7

- prepare compound 39 by reduction

### Example 8

- prepare guanidine analog 42

### Compounds 28-36 39-40 and 42 of Schemes 2 and 3

- provide NMR data for compounds 28-36, 39-40, and 42
- describe structural features of compounds
- report NMR spectra for each compound
- describe compounds 28-36, 39-40, and 42 of Schemes 2 and 3
- provide NMR data for Examples 26-31
- describe in vitro test for SphK1 and SphK2 inhibition
- present kinetic studies of Formula III (K145)
- describe cell viability assays and Western blot analysis
- present cell apoptosis assays and in vivo studies
- describe in vitro target validation of K145

